Maturitas
Volume 65, Issue 4 , Pages 359-365, April 2010

Does daily vitamin D 800IU and calcium 1000mg supplementation decrease the risk of falling in ambulatory women aged 65–71 years? A 3-year randomized population-based trial (OSTPRE-FPS)

  • Matti K. Kärkkäinen

      Affiliations

    • Bone and Cartilage Research Unit, University of Kuopio, Finland
    • Corresponding Author InformationCorresponding author at: Bone and Cartilage Research Unit, Mediteknia Building, University of Kuopio, P.O. Box 1627, 70211 Kuopio, Finland. Tel.: +358 50 5584698; fax: +358 17 162940.
  • ,
  • Marjo Tuppurainen

      Affiliations

    • Bone and Cartilage Research Unit, University of Kuopio, Finland
    • Department of Obstetrics and Gynecology, Kuopio University Hospital, Finland
  • ,
  • Kari Salovaara

      Affiliations

    • Bone and Cartilage Research Unit, University of Kuopio, Finland
    • Department of Orthopaedics, Traumatology and Handsurgery, Kuopio University Hospital, Finland
  • ,
  • Lorenzo Sandini

      Affiliations

    • Department of Internal Medicine, Kuopio University Hospital, Finland
  • ,
  • Toni Rikkonen

      Affiliations

    • Bone and Cartilage Research Unit, University of Kuopio, Finland
  • ,
  • Joonas Sirola

      Affiliations

    • Bone and Cartilage Research Unit, University of Kuopio, Finland
    • Department of Orthopaedics, Traumatology and Handsurgery, Kuopio University Hospital, Finland
  • ,
  • Risto Honkanen

      Affiliations

    • Bone and Cartilage Research Unit, University of Kuopio, Finland
    • Research Institute of Public Health, University of Kuopio, Finland
  • ,
  • Jari Arokoski

      Affiliations

    • Department of Physical and Rehabilitation Medicine, Kuopio University Hospital, Finland
  • ,
  • Esko Alhava

      Affiliations

    • Institute of Clinical Medicine, Surgery, University of Kuopio, Finland
  • ,
  • Heikki Kröger

      Affiliations

    • Bone and Cartilage Research Unit, University of Kuopio, Finland
    • Department of Orthopaedics, Traumatology and Handsurgery, Kuopio University Hospital, Finland

Received 5 October 2009; received in revised form 26 November 2009; accepted 16 December 2009. published online 31 December 2009.

Abstract 

Objective

The hypothesis was that the calcium and vitamin D supplementation prevents falls at the population level.Study design: The OSTPRE-FPS was a randomized population-based open-trial with 3-year follow-up. The supplementation group (n=1566) received daily cholecalciferol 800IU+calcium carbonate 1000mg, while the control group (n=1573) received no supplementation or placebo. A randomly selected subsample of 593 subjects underwent a detailed measurement program including serum 25(OH)D measurements.

Main outcome measure

The occurrence of falls was the primary outcome of the study. The participants in the subsample were telephoned at 4 months intervals and the rest of the trial population was interviewed by phone once a year.

Results

In the entire trial population (ETP), there were 812 women with 1832 falls in the intervention group and 833 women with 1944 falls in the control group (risk ratio was 0.98, 95% CI 0.92–1.05, P=0.160). The supplementation was not associated with single or multiple falls in the ETP. However, in the subsample, multiple fall incidence decreased by 30% (odds ratio (OR) 0.70, 95% CI 0.50–0.97, P=0.034) in the supplementation group. Further, the supplementation decreased the incidence of multiple falls requiring medical attention (OR 0.72, 95% CI 0.53–0.97, P=0.031) in the ETP. The mean compliance in the entire trial population was 78% and in the subsample 79%.

Discussion

Overall, the primary analysis showed no association between calcium and vitamin D supplementation and risk of falls. However, the results of a post hoc analysis suggested that there was a decreased risk of multiple falls requiring medical attention: this finding requires confirmation.

Keywords: Calcium, Falls, Population-based study, Randomized controlled trial, Vitamin D

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Trial Registration: Clinicaltrials.gov Identifier: NCT00592917.

PII: S0378-5122(09)00488-5

doi:10.1016/j.maturitas.2009.12.018

Maturitas
Volume 65, Issue 4 , Pages 359-365, April 2010